-
Je něco špatně v tomto záznamu ?
Brain networks underlying vulnerability and resilience to drug addiction
KD. Ersche, C. Meng, H. Ziauddeen, J. Stochl, GB. Williams, ET. Bullmore, TW. Robbins,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
Wellcome Trust - United Kingdom
Department of Health - United Kingdom
G0701497
Medical Research Council - United Kingdom
105602/Z/14/Z
Wellcome Trust - United Kingdom
104631/Z/14/Z
Wellcome Trust - United Kingdom
NLK
Free Medical Journals
od 1915 do Před 6 měsíci
Freely Accessible Science Journals
od 1915 do Před 6 měsíci
PubMed Central
od 1915 do Před 6 měsíci
Europe PubMed Central
od 1915 do Před 6 měsíci
Open Access Digital Library
od 1915-01-15
Open Access Digital Library
od 1915-01-01
PubMed
32541059
DOI
10.1073/pnas.2002509117
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- genetická predispozice k nemoci MeSH
- lidé MeSH
- mozek patofyziologie MeSH
- nervová síť fyziologie MeSH
- poruchy spojené s užíváním psychoaktivních látek * MeSH
- psychologie MeSH
- stimulanty centrálního nervového systému * MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Regular drug use can lead to addiction, but not everyone who takes drugs makes this transition. How exactly drugs of abuse interact with individual vulnerability is not fully understood, nor is it clear how individuals defy the risks associated with drugs or addiction vulnerability. We used resting-state functional MRI (fMRI) in 162 participants to characterize risk- and resilience-related changes in corticostriatal functional circuits in individuals exposed to stimulant drugs both with and without clinically diagnosed drug addiction, siblings of addicted individuals, and control volunteers. The likelihood of developing addiction, whether due to familial vulnerability or drug use, was associated with significant hypoconnectivity in orbitofrontal and ventromedial prefrontal cortical-striatal circuits-pathways critically implicated in goal-directed decision-making. By contrast, resilience against a diagnosis of substance use disorder was associated with hyperconnectivity in two networks involving 1) the lateral prefrontal cortex and medial caudate nucleus and 2) the supplementary motor area, superior medial frontal cortex, and putamen-brain circuits respectively implicated in top-down inhibitory control and the regulation of habits. These findings point toward a predisposing vulnerability in the causation of addiction, related to impaired goal-directed actions, as well as countervailing resilience systems implicated in behavioral regulation, and may inform novel strategies for therapeutic and preventative interventions.
Department of Clinical Neurosciences University of Cambridge Cambridge CB2 3EB United Kingdom
Department of Psychiatry University of Cambridge Cambridge CB2 0SZ United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20024938
- 003
- CZ-PrNML
- 005
- 20201222154942.0
- 007
- ta
- 008
- 201125s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1073/pnas.2002509117 $2 doi
- 035 __
- $a (PubMed)32541059
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Ersche, Karen D $u Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, United Kingdom; ke220@cam.ac.uk cm845@cam.ac.uk. Behavioural and Clinical Neuroscience Institute, Department of Psychology, University of Cambridge, Cambridge CB2 3EB, United Kingdom.
- 245 10
- $a Brain networks underlying vulnerability and resilience to drug addiction / $c KD. Ersche, C. Meng, H. Ziauddeen, J. Stochl, GB. Williams, ET. Bullmore, TW. Robbins,
- 520 9_
- $a Regular drug use can lead to addiction, but not everyone who takes drugs makes this transition. How exactly drugs of abuse interact with individual vulnerability is not fully understood, nor is it clear how individuals defy the risks associated with drugs or addiction vulnerability. We used resting-state functional MRI (fMRI) in 162 participants to characterize risk- and resilience-related changes in corticostriatal functional circuits in individuals exposed to stimulant drugs both with and without clinically diagnosed drug addiction, siblings of addicted individuals, and control volunteers. The likelihood of developing addiction, whether due to familial vulnerability or drug use, was associated with significant hypoconnectivity in orbitofrontal and ventromedial prefrontal cortical-striatal circuits-pathways critically implicated in goal-directed decision-making. By contrast, resilience against a diagnosis of substance use disorder was associated with hyperconnectivity in two networks involving 1) the lateral prefrontal cortex and medial caudate nucleus and 2) the supplementary motor area, superior medial frontal cortex, and putamen-brain circuits respectively implicated in top-down inhibitory control and the regulation of habits. These findings point toward a predisposing vulnerability in the causation of addiction, related to impaired goal-directed actions, as well as countervailing resilience systems implicated in behavioral regulation, and may inform novel strategies for therapeutic and preventative interventions.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a mozek $x patofyziologie $7 D001921
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 12
- $a stimulanty centrálního nervového systému $7 D000697
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nervová síť $x fyziologie $7 D009415
- 650 _2
- $a psychologie $7 D011584
- 650 12
- $a poruchy spojené s užíváním psychoaktivních látek $7 D019966
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Meng, Chun $u Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, United Kingdom; ke220@cam.ac.uk cm845@cam.ac.uk. Behavioural and Clinical Neuroscience Institute, Department of Psychology, University of Cambridge, Cambridge CB2 3EB, United Kingdom.
- 700 1_
- $a Ziauddeen, Hisham $u Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, United Kingdom. Cambridgeshire and Peterborough National Health Service Foundation Trust, Cambridge CB21 5EF, United Kingdom.
- 700 1_
- $a Stochl, Jan $u Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, United Kingdom. Department of Kinanthropology and Humanities, Charles University, 16252 Prague, Czech Republic.
- 700 1_
- $a Williams, Guy B $u Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 3EB, United Kingdom.
- 700 1_
- $a Bullmore, Edward T $u Department of Psychiatry, University of Cambridge, Cambridge CB2 0SZ, United Kingdom. Behavioural and Clinical Neuroscience Institute, Department of Psychology, University of Cambridge, Cambridge CB2 3EB, United Kingdom. Cambridgeshire and Peterborough National Health Service Foundation Trust, Cambridge CB21 5EF, United Kingdom.
- 700 1_
- $a Robbins, Trevor W $u Behavioural and Clinical Neuroscience Institute, Department of Psychology, University of Cambridge, Cambridge CB2 3EB, United Kingdom. Department of Psychology, University of Cambridge, Cambridge CB2 3EB, United Kingdom.
- 773 0_
- $w MED00010472 $t Proceedings of the National Academy of Sciences of the United States of America $x 1091-6490 $g Roč. 117, č. 26 (2020), s. 15253-15261
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32541059 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222154938 $b ABA008
- 999 __
- $a ok $b bmc $g 1599083 $s 1115624
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 117 $c 26 $d 15253-15261 $e 20200615 $i 1091-6490 $m Proceedings of the National Academy of Sciences of the United States of America $n Proc Natl Acad Sci U S A $x MED00010472
- GRA __
- $p Wellcome Trust $2 United Kingdom
- GRA __
- $p Department of Health $2 United Kingdom
- GRA __
- $a G0701497 $p Medical Research Council $2 United Kingdom
- GRA __
- $a 105602/Z/14/Z $p Wellcome Trust $2 United Kingdom
- GRA __
- $a 104631/Z/14/Z $p Wellcome Trust $2 United Kingdom
- LZP __
- $a Pubmed-20201125